Project Name: Supporting the MS Service with Pharmacist Staff Joint Working
Project Summary:
The Joint Working aims to recruit a multiple sclerosis (MS) Pharmacist to support the Trust MS service with the management, review, and follow-ups of MS patients. This will address the staff shortages being experienced by the Trust and help tackle the backlog of patients.
Specifically, via integrating the MS Pharmacist into all aspects of the service, the Joint Working aims to:
-
provide triaging and screening resource to review referrals and provide recommendations at multidisciplinary team (MDT) meetings;
-
improve patient outcomes and experience by reducing time between referral, diagnosis, and treatment, and increasing awareness of the MS pathway and empowerment of their care;
-
supporting the pharmacist team with management of patient databases.
Expected Benefits:
Expected Benefit to Patients
-
Improved patient outcomes due to faster time from referral to treatment time;
-
Improved access to NICE recommended therapy;
-
Enhanced patient experience of the NHS MS service by reducing unnecessary waiting times.
Expected Benefits to NHS
-
Improved quality of care;
-
Reduction in patient waiting lists;
-
Improved MDT efficiency and outcomes;
-
Improved experience of staff by spreading workload
-
Improved recovery of BlueTeq income
-
Increase in Clinical Nurse Specialist appointment activity
-
Increase in Pharmacist activity
Expected Benefit to Novartis
-
Learnings relating to the involvement of MS Pharmacists at MDTs;
-
Better understanding of overall customers’ and patients’ needs;
-
Optimal use of medicines (including Novartis medicines) in appropriate patients.
Start Date & Duration: Duration of JWA: 18 months from June 2022 – November 2023
UK | June 2022 | 465820